Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
  4. Volume 25, Issue 1
  5. Article
Volume 25, Issue 1
  • ISSN: 1871-5303
  • E-ISSN: 2212-3873

Abstract

Background

Currently, parathyroidectomy is the standard treatment for Primary Hyperparathyroidism (PHPT). Surgical treatment is often effective, although not free of complications and relapses. Minimally invasive techniques, such as Microwave Ablation (MWA) and Radiofrequency Ablation (RFA), are an alternative to surgery in selected patients. We have, herein, reported on the successful use of RFA in a patient with post-surgical persistent hyperparathyroidism.

Case Presentation

A 54-year-old woman was referred to our Center for mild hypercalcemia with exams revealing Primary Hyperparathyroidism (PHPT). Neck ultrasound and Technetium-99 Methoxy-isobutyl-isonitrile (99mTc-MIBI) scintigraphy scanning revealed a suspicious right parathyroid hyperplasia/adenoma. She underwent parathyroidectomy and histological examination showed a parathyroid nodular hyperplasia. During the follow-up, she suffered from persistent hyperparathyroidism due to a left parathyroid hyperplasia. Thus she was treated with RFA. Blood tests after the procedure showed the remission of the disease 7 months post-treatment.

Conclusion

A minimally invasive technique for PHPT may represent a valid alternative to surgery, especially in patients with an elevated surgery-related risk. More studies are necessary to investigate the benefit of RFA as a first-line treatment in PHPT.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303308277240419062634
2024-04-26
2025-01-17

  • From This Site

    /content/journals/emiddt/10.2174/0118715303308277240419062634
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MarcocciC. CetaniF. Primary hyperparathyroidism.Encycl. Endocr. Dis201812813810.1016/B978‑0‑12‑801238‑3.65217‑0
     [Google Scholar]
  2. HamdyN.A.T. Parathyroid gland: Is parathyroidectomy safe and beneficial in the elderly?Nat. Rev. Endocrinol.20095842242310.1038/nrendo.2009.142 19629065
     [Google Scholar]
  3. CaronN.R. SturgeonC. ClarkO.H. Persistent and recurrent hyperparathyroidism.Curr. Treat. Options Oncol.20045433534510.1007/s11864‑004‑0024‑4 15233910
     [Google Scholar]
  4. NawrotI. ChudzińskiW. CiąćkaT. BarczyńskiM. SzmidtJ. Reoperations for persistent or recurrent primary hyperparathyroidism: Results of a retrospective cohort study at a tertiary referral center.Med. Sci. Monit.2014201604161210.12659/MSM.890983 25201515
     [Google Scholar]
  5. WeiY. PengC-Z. WangS-R. HeJ-F. PengL-L. ZhaoZ-L. CaoX-J. LiY. YuM-A. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: A multicenter study.J. Clin. Endocrinol. Metab.202110692707271710.1210/clinem/dgab240 33846740
     [Google Scholar]
  6. WalkerM.D. SilverbergS.J. Primary hyperparathyroidism.Nat. Rev. Endocrinol.201814211512510.1038/nrendo.2017.104 28885621
     [Google Scholar]
  7. MarcocciC. SaponaroF. Epidemiology, pathogenesis of primary hyperparathyroidism: Current data.Ann. Endocrinol.201576211311510.1016/j.ando.2015.03.015 25916761
     [Google Scholar]
  8. YehM.W. ItuarteP.H.G. ZhouH.C. NishimotoS. LiuI.L. HarariA. HaighP.I. AdamsA.L. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.J. Clin. Endocrinol. Metab.20139831122112910.1210/jc.2012‑4022 23418315
     [Google Scholar]
  9. GriebelerM.L. KearnsA.E. RyuE. HathcockM.A. MeltonL.J.III WermersR.A. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).Bone2015731710.1016/j.bone.2014.12.003 25497786
     [Google Scholar]
  10. SilverbergS.J. ShaneE. JacobsT.P. SirisE. BilezikianJ.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.N. Engl. J. Med.1999341171249125510.1056/NEJM199910213411701 10528034
     [Google Scholar]
  11. BilezikianJ.P. BrandiM.L. EastellR. SilverbergS.J. UdelsmanR. MarcocciC. PottsJ.T.Jr Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop.J. Clin. Endocrinol. Metab.201499103561356910.1210/jc.2014‑1413 25162665
     [Google Scholar]
  12. GuerinC. PaladinoN.C. LoweryA. CastinettiF. TaiebD. SebagF. Persistent and recurrent hyperparathyroidism.Updates Surg.201769216116910.1007/s13304‑017‑0447‑7 28434176
     [Google Scholar]
  13. RichardsM.L. ThompsonG.B. FarleyD.R. GrantC.S. Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring.Am. J. Surg.2008196693794210.1016/j.amjsurg.2008.07.022 19095113
     [Google Scholar]
  14. KimB.S. EomT.I. KangK.H. ParkS.J. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism.J. Med. Ultrason.201441223924310.1007/s10396‑013‑0501‑0 27277780
     [Google Scholar]
  15. XuS.Y. WangY. XieQ. WuH.Y. Percutaneous sonography-guided radiofrequency ablation in the management of parathyroid adenoma.Singapore Med. J.2013547e137e14010.11622/smedj.2013092 23900476
     [Google Scholar]
  16. MauriG. GennaroN. LeeM.K. BaekJ.H. Laser and radiofrequency ablations for benign and malignant thyroid tumors.Int. J. Hyperthermia2019362132010.1080/02656736.2019.1622795 31537159
     [Google Scholar]
  17. EbrahiminikH. ChegeniH. Mosadegh KhahA. SaloutiR. GhomashchiG. Deldar PasikhaniM. HeydariI. ShamsiK. BeiranvandB. Azimi AvalM.R. MohammadiA. Mirza-Aghazadeh-AttariM. FadaeeN. Radiofrequency ablation of parathyroid adenomas causing primary hyperparathyroidism: A report of 27 patients.J. Clin. Ultrasound202250454054610.1002/jcu.23181 35278235
     [Google Scholar]
  18. PengC.Z. ChaiH.H. ZhangZ.X. HuQ.H. ZengZ. CuiA.L. PangH.S. RuanL.T. Radiofrequency ablation for primary hyperparathyroidism and risk factors for postablative eucalcemic parathyroid hormone elevation.Int. J. Hyperthermia202239149049610.1080/02656736.2022.2047231 35285391
     [Google Scholar]
/content/journals/emiddt/10.2174/0118715303308277240419062634
Loading
Post-surgical Persistent Hyperparathyroidism Successfully Treated with Parathyroid Radiofrequency Ablation: A Case Report
Endocr Metab Immune Disord Drug Targets 25, 80 (2025); https://doi.org/10.2174/0118715303308277240419062634
/content/journals/emiddt/10.2174/0118715303308277240419062634
/content/journals/emiddt/10.2174/0118715303308277240419062634
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): hypercalcemia; minimally invasive technique; parathyroid surgery; parathyroidectomy; persistent hyperparathyroidism; Primary hyperparathyroidism; radiofrequency ablation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test